Within a mouse product, offering genetic validation of CRK12:CYC9 as a novel drug target for trypanosomiasis. Further more, useful characterisation of CRK12 and CYC9 using RNA interference reveals roles for these proteins in endocytosis and cytokinesis, respectively. Safety and efficacy of targeting platelet proteinase-activated receptors in combination with existing anti-platelet https://matthewi554vci5.liberty-blog.com/profile